BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38553942)

  • 1. The quantitative parameters based on marrow metabolism derived from synthetic MRI: A pilot study of prognostic value in participants with newly diagnosed multiple myeloma.
    Cui S; Guo Y; Niu W; Li J; Bian W; Wu W; Zhang W; Zheng Q; Wang J; Niu J
    Cancer Med; 2024 Apr; 13(7):e7109. PubMed ID: 38553942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a whole spinal MRI-based tumor burden scoring method in participants with multiple myeloma: a pilot study of prognostic significance.
    Cui S; Guo Y; Li J; Bian W; Wu W; Zhang W; Zheng Q; Guan H; Wang J; Niu J
    Ann Hematol; 2024 May; 103(5):1665-1673. PubMed ID: 38326481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histogram Analysis Based on Apparent Diffusion Coefficient Maps of Bone Marrow in Multiple Myeloma: An Independent Predictor for High-risk Patients Classified by the Revised International Staging System.
    Wang Q; Zhang L; Li S; Sun Z; Wu X; Zhao A; Benkert T; Zhou D; Xue H; Jin Z; Li J
    Acad Radiol; 2022 Jun; 29(6):e98-e107. PubMed ID: 34452820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
    Ailawadhi S; Abdelhalim AN; Derby L; Mashtare TL; Miller KC; Wilding GE; Alberico RA; Gottlieb R; Klippenstein DL; Lee K; Chanan-Khan AA
    Cancer; 2010 Jan; 116(1):84-92. PubMed ID: 19862816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Analysis of Whole-Body MRI for Accessing the Degree of Diffuse Infiltration Patterns and Identifying High Risk Cases of Newly Diagnosed Multiple Myeloma.
    Sun M; Wang L; Wang C; Ma J; Wang W; Lin L; Ren C; Zhang Y; Cheng J
    J Magn Reson Imaging; 2024 Jun; 59(6):2035-2045. PubMed ID: 37675995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.
    Takasu M; Kondo S; Akiyama Y; Takahashi Y; Maeda S; Baba Y; Kawase T; Ichinohe T; Awai K
    PLoS One; 2020; 15(2):e0229607. PubMed ID: 32106239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time Course Changes of Synthetic Relaxation Time During Neoadjuvant Chemotherapy in Breast Cancer: The Optimal Parameter for Treatment Response Evaluation.
    Zhao R; Du S; Gao S; Shi J; Zhang L
    J Magn Reson Imaging; 2023 Oct; 58(4):1290-1302. PubMed ID: 36621982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
    Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB
    Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.
    Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Hillengass M; Wagner B; Hose D; Raab MS; Jauch A; Delorme S; Goldschmidt H; Weber MA; Hillengass J
    Eur Radiol; 2016 Nov; 26(11):3939-3948. PubMed ID: 26767378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram analysis of quantitative parameters from synthetic MRI: correlations with prognostic factors in nasopharyngeal carcinoma.
    Yang F; Li X; Li Y; Lei H; Du Q; Yu X; Li L; Zhao Y; Xie L; Lin M
    Eur Radiol; 2023 Aug; 33(8):5344-5354. PubMed ID: 37036478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of MRI Features of Fat Fraction and ADC for Early Treatment Response Assessment in Participants with Multiple Myeloma.
    Koutoulidis V; Terpos E; Papanikolaou N; Fontara S; Seimenis I; Gavriatopoulou M; Ntanasis-Stathopoulos I; Bourgioti C; Santinha J; Moreira JM; Kastritis E; Dimopoulos MA; Moulopoulos LA
    Radiology; 2022 Jul; 304(1):137-144. PubMed ID: 35380497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.
    Zhang L; Wang Q; Wu X; Zhao A; Feng J; Zhang H; Cao X; Li S; Cai H; Sun Z; Duan M; Zhu T; Zhang W; Jin Z; Zhou D; Xue H; Li J
    Eur Radiol; 2021 Apr; 31(4):1843-1852. PubMed ID: 32965573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy.
    Paschali A; Panagiotidis E; Triantafyllou T; Palaska V; Tsirou K; Verrou E; Ī„iannaki E; Markala D; Papanikolaou A; Pouli A; Konstantinidou P; Chatzipavlidou V; Terpos E; Katodritou E
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1487-1497. PubMed ID: 33099659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: the role of albumin in the model.
    Mihou D; Katodritou E; Zervas K
    Hematology; 2007 Dec; 12(6):527-31. PubMed ID: 17852450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients.
    Bila J; Jelicic J; Dencic Fekete M; Trajkovic G; Sretenovic A; Perunicic Jovanovic M; Antic D; Mihaljevic B
    Oncol Res Treat; 2017; 40(10):616-620. PubMed ID: 28950269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Preoperative Diagnostic Performance of Multi-Parametric Quantitative Assessment in Rectal Carcinoma: A Preliminary Study Using Synthetic Magnetic Resonance Imaging.
    Zhu K; Chen Z; Cui L; Zhao J; Liu Y; Cao J
    Front Oncol; 2022; 12():682003. PubMed ID: 35707367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.